Vendor, St. Gallen, CHE
Universitat St. Gallen
UEI LLK6D5M1UAF1, CAGE SZA17
3 awards and $950,949 obligated between April 10, 2024 and September 18, 2026, 100% under full and open competition, against 1.0 offers on average where reported. 9 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $515,770 |
| Colleges, Universities, and Professional SchoolsNAICS 611310 | $435,179 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
| Definitive Contract | 3 |
Hear when Universitat St. Gallen wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Universitat St. Gallen holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $435,179
- Soonest
- September 29, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Food and Drug Administration, by dollars.
| President and Fellows of Harvard CollegeCambridge, MA | $10,869,531 |
| Dna Hive LLCRockville, MD | $7,461,715 |
| Tranquil Clinical and Research Consulting Services LLCWebster, TX | $4,117,132 |
| The Research Foundation for the State University of New YorkBinghamton, NY | $3,684,500 |
| Aptargroup Inc.Congers, NY | $2,958,579 |
| The Critical Path InstituteTucson, AZ | $2,672,572 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40125C00063Definitive Contract, September 8, 2025, Full and Open Competition, 1 offersSolicitation | FDA Office of Acq Grant SVCSFood and Drug Administration | The Purpose of This Contract Is to Conduct Research and Develop Tools to Strengthen Post-Market Surveillance of Fda-Regulated Products. the NAICS 541714, PSC AJ11 | $515,770 |
| 75F40126C00070Definitive Contract, September 18, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | BAA Contract- Fy26c2dp2-Beyond Compliance: Integrating Quality Culture and Risk in Pharmaceutical Quality ManagementNAICS 611310, PSC AJ11 | $435,179 |
| 75F40121C00161Definitive Contract, April 10, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Following the Publication of the US Food and Drug Administration Safety and Innovation Act (Fdasia) in 2012, and the Subsequent EstablishmenNAICS 541714, PSC AN11 | -$0 |
- Places of performance
- Maryland
- Product and service codes
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic ResearchAN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 3 across 3 awards